PROFUND ADVISORS LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 109 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$430,007
+20.3%
9,350
+50.4%
0.02%
+26.3%
Q2 2023$357,348
+67.0%
6,218
+4.3%
0.02%
+111.1%
Q1 2022$214,000
-19.2%
5,963
-55.2%
0.01%
-43.8%
Q4 2018$265,000
-29.0%
13,312
-31.3%
0.02%
+14.3%
Q3 2018$373,00019,3710.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders